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Background 
Bupropion is a norepinephrine and 
dopamine reuptake inhibitor used for 
depression, tobacco cessation and  
ADHD. Overdose can result in significant 
neurological and cardiovascular  toxicity 
including – lethargy, seizures, QRS/QT 
prolongation, and cardiogenic shock. 
Extended release formulations may result  
in delayed or prolonged toxicity. Therefore, 
gastric decontamination methods such  
as activated charcoal and whole bowel 
irrigation (WBI) may be  considered to limit 
drug adsorption, and  decrease transit time 
and absorption. However, gastrointestinal 
decontamination remains  controversial, 
particularly in ingestions typically resulting  
in depressed mental status or seizures.
Discussion
We present a case series of three patients 
with severe bupropion toxicity successfully 
managed with gastric decontamination in 
conjunction with supportive care.  
Conclusion
These cases highlight the positive outcomes and effectiveness of activated charcoal and WBI in the setting 
of severe bupropion toxicity. In a patient with a secured or stable airway and a significant ingestion of 
bupropion, these treatment regimens may be considered in addition to supportive care. Additional studies 
should be conducted to better understand efficacy of gastric decontamination and WBI in bupropion overdoses.
A 48-year-old male ingested 30-60 
tablets of 300mg bupropion XL in a 
suicide attempt. He presented to the emergency 
department (ED) with a depressed mental 
status and myoclonic movement, and was 
subsequently intubated. He developed QTc 
(571ms) and QRS (170ms) prolongation. The 
patient presented within two hours of 
ingestion and pill fragments were visible  
on a computed tomography (CT) of the 
abdomen and pelvis. Activated charcoal was 
administered. WBI was then initiated with 
polyethylene glycol (PEG) until clear rectal 
effluent. Additional treatment included 
magnesium sulfate for QT prolongation, 
phenobarbital and propofol for myoclonic  
jerks and sedation, and bicarbonate for QRS 
prolongation. The patient’s cardiac intervals 
and clinical status improved and the patient 
was extubated on hospital day (HD) 7 and 
discharged to psychiatric care. 
A 21-year-old female ingested bupropion, 
hydroxyzine and alcohol and then was 
involved in a high speed MVC and suffered several 
traumatic injuries. CT imaging showed a significant 
number of pills in her stomach. Approximately 12 hours 
after her arrival to the ED, the patient experienced 
multiple seizures, prolonged QRS (100ms) and QTc 
(615ms). WBI was initiated with PEG, and additional 
treatments included magnesium sulfate, bicarbonate, 
vasopressors, and intralipid emulsion. She developed 
dysrhythmias and cardiogenic shock and was 
stabilized on intra-aortic balloon pump (IABP) and 
vasopressors. QRS and QT normalized with improved 
hemodynamics and the patient was discharged to 
inpatient psychiatric care on HD 14. 
A 14-year-old female presented with  
a polypharmacy overdose including  
30-60 tablets of 300mg XL bupropion, 
fluoxetine, acetaminophen and naproxen. The 
patient experienced multiple seizures requiring 
intubation for airway protection. The patient 
continued to have seizures and myoclonic jerks  
that did not respond well to benzodiazepines as well 
as QRS widening (100ms) and QTc prolongation 
(526ms). The patient was loaded with phenobarbital 
and WBI was initiated. The patient was extubated  
on HD 3 and was discharged to psychiatric care. 
